ParetoHealth expands leadership with new CRO and CUO

ParetoHealth, a risk financing platform for employee health benefits, has expanded its leadership team with the additions of Jason Meador (pictured left) as chief underwriting officer (CUO) and Kevin Kickhaefer (pictured right) as chief revenue officer (CRO).

"Kevin and Jason are mission-oriented leaders who are committed to helping improve health benefits for small and midsize businesses," said Maeve O'Meara, chief executive of ParetoHealth. "Their expertise will enable us to continue to grow at scale, deliver for our partners and customers, and stay ahead in a rapidly evolving market."

As CUO, Meador will lead the underwriting organisation and be responsible for risk management. Most recently, he served as executive vice president of direct markets at Zurich North America after holding multiple leadership roles, including head of group captives. Before Zurich, he was at The Boston Consulting Group, where he spent almost a decade advising insurance companies. He began his career in the US Navy. 

"I'm excited to partner with a great team to leverage the company's industry-leading scale and performance to drive further growth and innovation for the community," said Meador.

As CRO, Kickhaefer will lead sales, marketing, and customer management to build on the company's momentum and ensure a consistent, best-in-class experience for consultants and employers. Kickhaefer has a proven track record of scaling innovative organisations, having previously served as CEO of consumer medical and president and chief growth officer at Gravie. He began his career with Cigna and Aetna.

"ParetoHealth is empowering consultants and employers to take control of their future," said Kickhaefer. "I'm excited to join an organisation that's delivering a solution purpose-built to provide savings, stability, and control in a space that has lacked all three."

Did you get value from this story?  Sign up to our free daily newsletters and get stories like this sent straight to your inbox.